RESULTS PROVEN IN CLINICAL RESEARCH
Dr. Kenneth Brown and his team of scientists created Atrantíl based on their understanding of how its three main natural botanicals would work together to relieve Irritable Bowel Syndrome (IBS) , Small Intestinal Bacterial Overgrowth (SIBO), bloating, abdominal discomfort and changes in bowel habits—constipation, diarrhea or both. And to prove their formula was more than just a good idea, they tested it twice with real patients.
DOUBLE-BLIND TRIAL In a double-blind study of patients suffering from Irritable Bowel Syndrome (IBS) , Small Intestinal Bacterial Overgrowth (SIBO),bloating, constipation and abdominal discomfort, Atrantíl proved to be more than 88 percent effective in relieving symptoms. The leading two prescription therapies didn’t perform as well versus a placebo according to their own studies. The results of the trial were published in the Journal of Gastroenterology and Hepatology Research – September 21, 2015 pp. 1762-1767.
OPEN-LABEL TRIAL The open-label trial targeted the toughest-to-treat patients to illustrate the efficacy of Atrantíl. Before beginning the trial, patients qualified to participate only after failing to find relief from at least four prescription therapies. The trial showed that 80 percent of patients found relief after using Atrantíl to control their Irritable Bowel Syndrome (IBS) , Small Intestinal Bacterial Overgrowth (SIBO),bloating, constipation and abdominal discomfort. The results of the trial were published in the World Journal of Gastrointestinal Pharmacology and Therapeutics – August 6, 2016 pp. 463-468.